全球RA治疗建议:来自各个国际协会的最新情况
Charles Cubberley1, Ajesh Maharaj2
1Oregon Health & Science University, Portland, OR, USA.
Best practice & research. Clinical rheumatology
|November 4, 2024
概括
本综述更新了全球风湿病学协会的风湿性关节炎治疗建议. 它解决了全球风湿性关节炎管理的挑战和解决方案,重点关注最近的指南.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 内部医学 内部医学
背景情况:
- 类风湿性关节炎 (RA) 是一种慢性炎症疾病,具有显著的关节外表现.
- RA 与增加的发病率和死亡率有关,突显了有效管理的必要性.
研究的目的:
- 提供全球类风湿性关节炎治疗建议的最新概述.
- 讨论全球类风湿关节炎护理中的挑战和潜在解决方案.
主要方法:
- 在PubMed,谷歌学者和EMBASE (2000-2024) 上进行了全面的文献搜索.
- 搜索术语包括"类风湿关节炎"",治疗"",建议"",指南"",管理"",差异"和"访问".
- 重点是过去五年出版的指南,重点是ACR,EULAR,APLAR,PANLAR和AFLAR.
主要成果:
- 该综述综合了主要国际风湿病学协会最新的治疗建议.
- 确定了全球类风湿性关节炎管理中的关键差异和获取问题.
结论:
- 更新的全球指南为优化类风湿性关节炎治疗提供了一个框架.
- 解决差距和改善接入是全球性风湿性关节炎公平护理的关键.
相关概念视频
Rheumatic Heart Disease III: Medical Management
3
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
3
Rheumatic Heart Disease IV: Nursing Management
5
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
5
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
117
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
117
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
143
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
143
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
7
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
7


